trial

Estimating Prevalence of Inherited Disorders of Sulfur Amino Acids Metabolism in Patients With Psychotic Disorders.

NCTId NCT05206292
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 600 (estimated)
Sponsored by University Hospital, Grenoble
Primary completion 2025-01-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
600 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2023-01-12
Primary completion
2025-01-01
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Sulfitest

Sponsors

University Hospital, GrenobleLead Sponsor

Investigators

1
Gérard BessonPrincipal Investigator

Sites

1 total
Grenoble, France

Facts & assertions

4 sourced
Enrollment
600
Phase
NA
Primary Completion Date
2025-01-01
Status
UNKNOWN
relationships
The graph out of here
drug
Sulfitest
drug
lead_sponsor
University Hospital, Grenoble
company
indication
Schizophrenia
indication
Schizophrenia
indication
Inherited Metabolic Disorder of Nervous System
indication
investigator
Gérard Besson
person